JP2002502979A - ヘパリンによる干渉なしのトロポニンアッセイ - Google Patents

ヘパリンによる干渉なしのトロポニンアッセイ

Info

Publication number
JP2002502979A
JP2002502979A JP2000530804A JP2000530804A JP2002502979A JP 2002502979 A JP2002502979 A JP 2002502979A JP 2000530804 A JP2000530804 A JP 2000530804A JP 2000530804 A JP2000530804 A JP 2000530804A JP 2002502979 A JP2002502979 A JP 2002502979A
Authority
JP
Japan
Prior art keywords
troponin
heparin
polybrene
assay
heart
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000530804A
Other languages
English (en)
Japanese (ja)
Inventor
イザベル・カリーヌ・ジュリアニ
カテリーヌ・クリスティアンヌ・マリ・ラリュ
モーリス・プティトゥ
シルヴィ・マリ−フランス・トランキエ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bio Rad Innovations SAS
Original Assignee
Bio Rad Pasteur SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Rad Pasteur SA filed Critical Bio Rad Pasteur SA
Publication of JP2002502979A publication Critical patent/JP2002502979A/ja
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4712—Muscle proteins, e.g. myosin, actin, protein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
JP2000530804A 1998-02-05 1999-02-01 ヘパリンによる干渉なしのトロポニンアッセイ Pending JP2002502979A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9801367A FR2774473B1 (fr) 1998-02-05 1998-02-05 Procede de dosage des troponines dans des milieux biologiques permettant d'eviter les interferences dues a l'heparine
FR98/01367 1998-02-05
PCT/FR1999/000198 WO1999040442A1 (fr) 1998-02-05 1999-02-01 Dosage des troponines sans interferences dues a l'heparine

Publications (1)

Publication Number Publication Date
JP2002502979A true JP2002502979A (ja) 2002-01-29

Family

ID=9522644

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000530804A Pending JP2002502979A (ja) 1998-02-05 1999-02-01 ヘパリンによる干渉なしのトロポニンアッセイ

Country Status (4)

Country Link
EP (1) EP1051623A1 (fr)
JP (1) JP2002502979A (fr)
FR (1) FR2774473B1 (fr)
WO (1) WO1999040442A1 (fr)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010513917A (ja) * 2006-12-22 2010-04-30 ヒューマニタス・ミラソーレ・エス．ピー．エー． ロングペントラキシンｐｔｘ３の血漿レベルを測定するための方法
JP2011038903A (ja) * 2009-08-11 2011-02-24 Kanto Chem Co Inc 水溶性アンモニウムポリマーを含有する検体前処理試薬、および検体前処理方法
WO2012115221A1 (fr) 2011-02-25 2012-08-30 三菱化学メディエンス株式会社 Procédé de mesure de la troponine myocardique
WO2014021387A1 (fr) * 2012-07-31 2014-02-06 積水メディカル株式会社 Dosage immunologique d'inhibition de l'agglutination du latex
WO2017179611A1 (fr) * 2016-04-13 2017-10-19 株式会社Ｌｓｉメディエンス Dosage immunologique utlisant un polysaccharide sulfaté

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004510161A (ja) * 2000-09-25 2004-04-02 アボット・ラボラトリーズ 高分子ポリカチオンを用いることにより、特異的結合アッセイにおける血清または血漿含有アッセイ試料の干渉を減少させるための方法及びキット
WO2002063302A1 (fr) * 2001-02-07 2002-08-15 Immunomatrix Inc. Technique permettant de reduire l'interference de l'heparine dans des essais diagnostic de la troponine cardiaque
CN102426246A (zh) * 2011-08-31 2012-04-25 内蒙古科慧生物科技有限责任公司 人肌钙蛋白I(Troponin I)定量测定试剂盒及其检测方法
CN108291911A (zh) * 2015-10-30 2018-07-17 美迪恩斯生命科技株式会社 凝血酶-抗凝血酶复合体的测定试剂及测定方法

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010513917A (ja) * 2006-12-22 2010-04-30 ヒューマニタス・ミラソーレ・エス．ピー．エー． ロングペントラキシンｐｔｘ３の血漿レベルを測定するための方法
JP2011038903A (ja) * 2009-08-11 2011-02-24 Kanto Chem Co Inc 水溶性アンモニウムポリマーを含有する検体前処理試薬、および検体前処理方法
CN103380377B (zh) * 2011-02-25 2016-01-27 美迪恩斯生命科技株式会社 心肌肌钙蛋白的测定方法
CN103380377A (zh) * 2011-02-25 2013-10-30 三菱化学美迪恩斯株式会社 心肌肌钙蛋白的测定方法
KR20140007449A (ko) 2011-02-25 2014-01-17 미쓰비시 가가쿠 메디엔스 가부시키가이샤 심근 트로포닌의 측정법
WO2012115221A1 (fr) 2011-02-25 2012-08-30 三菱化学メディエンス株式会社 Procédé de mesure de la troponine myocardique
US10634681B2 (en) 2011-02-25 2020-04-28 Lsi Medience Corporation Method for measuring cardiac troponin
WO2014021387A1 (fr) * 2012-07-31 2014-02-06 積水メディカル株式会社 Dosage immunologique d'inhibition de l'agglutination du latex
JPWO2014021387A1 (ja) * 2012-07-31 2016-07-21 積水メディカル株式会社 ラテックス凝集阻害免疫法
US10627393B2 (en) 2012-07-31 2020-04-21 Sekisui Medical Co., Ltd. Latex agglutination inhibition immunoassay
WO2017179611A1 (fr) * 2016-04-13 2017-10-19 株式会社Ｌｓｉメディエンス Dosage immunologique utlisant un polysaccharide sulfaté
JPWO2017179611A1 (ja) * 2016-04-13 2019-02-21 株式会社Ｌｓｉメディエンス 硫酸化多糖類を用いた免疫学的測定法
US11422128B2 (en) 2016-04-13 2022-08-23 Lsi Medience Corporation Immunoassay employing sulfated polysaccharide

Also Published As

Publication number Publication date
WO1999040442A1 (fr) 1999-08-12
FR2774473A1 (fr) 1999-08-06
FR2774473B1 (fr) 2000-05-12
EP1051623A1 (fr) 2000-11-15

Similar Documents

Publication Publication Date Title
US6174686B1 (en) Methods for the assay of troponin I and T and complexes of troponin I and T and selection of antibodies for use in immunoassays
US6991907B1 (en) Methods for the assay of troponin I and T and complexes of troponin I and T and selection of antibodies for use in immunoassays
US5947124A (en) Diagnostic for determining the time of a heart attack
Okamoto et al. Human heart-type cytoplasmic fatty acid-binding protein (H-FABP) for the diagnosis of acute myocardial infarction. Clinical evaluation of H-FABP in comparison with myoglobin and creatine kinase isoenzyme MB
EP0821794B1 (fr) Nouveaux procedes de dosage de la troponine i et t et de ses complexes, et selection d'anticorps utilises dans des dosages immunologiques
US7638292B2 (en) Immunoassay
JP3357163B2 (ja) 免疫学的測定用トロポニン安定化組成物および安定化法
Aartsen et al. Heart fatty acid binding protein and cardiac troponin T plasma concentrations as markers for myocardial infarction after coronary artery ligation in mice
Oyama et al. Validation of an immunoassay for measurement of canine cardiac troponin-I
US7550269B2 (en) PTX3 as an early prognostic indicator of cardiovascular and cerebrovascular pathologies
JP3558643B2 (ja) 心臓トロポニンｉの超高感度アッセイ法
WO2012175602A2 (fr) Quantification de la calprotectine par elisa
JP2002502979A (ja) ヘパリンによる干渉なしのトロポニンアッセイ
JP2010513917A (ja) ロングペントラキシンｐｔｘ３の血漿レベルを測定するための方法
Pervan et al. Urine concentrations of high-sensitivity cardiac troponin I in healthy adults–preliminary reference intervals
Wu Cardiac markers: from enzymes to proteins, diagnosis to prognosis, laboratory to bedside
Chapelle et al. Automated quantification of creatine kinase MB isoenzyme in serum by radial partition immunoassay, with use of the Stratus analyzer
Parry et al. False positive analytical interference of cardiac troponin I assays: an important consideration for method selection
Sacks Acute coronary ischemia: troponin I and T
Oh et al. Use of a dual monoclonal solid phase and a polyclonal detector to create an immunoassay for the detection of human cardiac troponin I
Tate et al. Measurement of cardiac troponins revisited
Kao et al. Comparison of Abbott AxSYM, Behring Opus Plus, DPC Immulite and Ortho-Clinical Diagnostics Vitros ECi for measurement of cardiac troponin I
Panteghini Clinical and analytical performance of automated immunochemiluminometric assays for determination of cardiac markers in serum
PERVAN et al. KONCENTRACIJE SRČANOG VISOKOOSJETLJIVOG TROPONINA IU MOKRAĆI ZDRAVIH OSOBA–PRELIMINARNI REFERENTNI INTERVALI
Sodi Cardiac troponins: clinical and analytical aspects